Download this entire issue or browse individual articles by title below.
![]() |
Front Cover |
Front Cover | ||
1 | Letter from the MAPS President | Rick Doblin, Ph.D. |
2 | Table of Contents | |
3 | MDMA Neurotoxicity Research: Methodological Concerns | Charles Grob, M.D. |
4 | MDMA Neurotoxicity Discussed | Rick Doblin, Ph.D. |
6 | MDMA and Memory Impairment: Proven or Not Proven? | K. Thomas Nelson, Ph.D. |
9 | Reviewing the Latest Research with MDMA and MDE: Introduction to a recent MAPS organized conference | |
11 | Proposal for a Study with MDMA and Post Traumatic Stress Disorder in Spain | Jose Carlos Bouso Saiz |
15 | MDMA in a Couple Struggling with Cancer: Two Years Later | Sue |
18 | Cannabis in Migraine Treatment Project Moves Closer to FDA Approval | Ethan Russo, M.D. |
19 | MAPS Succeeds in Securing an Orphan Drug Designation for Marijuana | Rick Doblin, Ph.D. |
20 | Medical Cannabis Potency Testing | Dale Gieringer, Ph.D. |
23 | Do Entheogen-Induced Mystical Experiences Boost the Immune System? | Thomas B. Roberts, Ph.D. |
32 | Back Cover |